ras

Documents about ras

• Functional specific roles of H-ras and N-ras. A proteomic approach using knockout cell lines#337354Gestión del Repositorio Documental de la Universidad de Salamanca
• Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations#1152609ClinicalTrials.gov
• 40 years of RAS—a historic overview#294467Gestión del Repositorio Documental de la Universidad de Salamanca
• Raw Data for HLA-B27 and RAS Mutations in Colorectal Cancer Study#296714Figshare
• Ras GEF mouse models for the analysis of ras biology and signaling#294495Gestión del Repositorio Documental de la Universidad de Salamanca
• Anthraquinones as inhibitors of SOS RAS-GEF activity#294468Gestión del Repositorio Documental de la Universidad de Salamanca
• Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma#1377086ClinicalTrials.gov
• Small-molecule RAS/RAF inhibitors target RAS-driven cancers via allosteric RAF disruption.#610523NCBI PubMed Central
• The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment#1295767ClinicalTrials.gov
• Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)#1212138ClinicalTrials.gov
• p73 cooperates with Ras in the activation of MAP kinase signaling cascade#294489Gestión del Repositorio Documental de la Universidad de Salamanca
• RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer#1280478ClinicalTrials.gov
• GST101 in Participants With RAS-Mutant Advanced Solid Tumors#1340175ClinicalTrials.gov
• Generierung von K-Ras(G12C)-Inhibitor-resistenten Lungen- und Pankreaskarzinomzellen zur Charakterisierung von Signalwegen, die eine adaptive Resistenz gegen K-Ras(G12C)- Inhibitoren vermitteln#334398JLUpub
• Stories of the Prophets#1302249Open Library
• RAS Quantification in Patients With Aliskiren or Candesartan#1497602ClinicalTrials.gov
• Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer#899491ClinicalTrials.gov
• Laser microdissection and microarray analysis of the hippocampus of Ras-GRF1 knockout mice reveals gene expression changes affecting signal transduction pathways related to memory and learning#294488Gestión del Repositorio Documental de la Universidad de Salamanca
• Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients#1128316ClinicalTrials.gov
• Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer#1475579ClinicalTrials.gov
• The HEC-RAS computation modeling results for forecasting climate driven hydrodynamic shifts in the lower Nemunas River using an integrated HEC-RAS, SWAT, SHYFEM modeling toolchain#124769DataCite
• The HEC-RAS computation modeling results for forecasting climate driven hydrodynamic shifts in the lower Nemunas River using an integrated HEC-RAS, SWAT, SHYFEM modeling toolchain#124770DataCite
• I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations#867634ClinicalTrials.gov
• A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer#1445976ClinicalTrials.gov
• Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations#883518ClinicalTrials.gov
• Interrogating the immune landscape of microsatellite stable RAS ‐mutated colon cancer#246654HAL (France)
• Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer#1150835ClinicalTrials.gov
• Analisis Performa Metode YOLOv5-CNN Dalam Meningkatkan Deteksi Dan Pengenalan Ras Kelinci#194649Jutisi : Jurnal Ilmiah Teknik Informatika dan Sistem Informasi
• Analisis Performa Metode YOLOv5-CNN Dalam Meningkatkan Deteksi Dan Pengenalan Ras Kelinci#194850Publikasi Ilmiah STMIK Banjarbaru
• RAS Switch in Patients With Metastatic RAS Native Colorectal Tumors Treated With 1st Line FOLFIRI-Cetuximab#1410212ClinicalTrials.gov
• Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation#1421297ClinicalTrials.gov
• RIPOR2 promotes multinucleation of melanoma cells downstream of the RAS/ERK oncogenic pathway#430214HAL (France)
• STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer#1161715ClinicalTrials.gov
• Robotic Surgery in the Treatment of Deep Endometriosis: Da Vinci Vs HUGO RAS Comparison#1378005ClinicalTrials.gov
• Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favorable FcγRIIa (CD32) Genotype#1420322ClinicalTrials.gov
• Constitutively active RAS prolongs Cdc42 signalling, while MAPK signalling is attenuated during fission yeast mating#30969PLOS
• Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation#858446ClinicalTrials.gov
• Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino)#981636ClinicalTrials.gov
• A Study of HRS-2329 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications#1007895ClinicalTrials.gov
• Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension#1197714ClinicalTrials.gov
• RAS: Measuring LLM Safety Through Refusal Alignment#306955arXiv CS
• From the President’s desk: Part 3, 2026#919213African Journals Online
• PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC#1394776ClinicalTrials.gov
• A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression#1421515ClinicalTrials.gov
• Aplicação do HEC-RAS na Modelagem Hidráulica da Ponte sobre o Ribeirão Brioso na MS-320#412956Repositório Institucional da Universidade Federal de Mato Grosso do Sul
• FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer#902661ClinicalTrials.gov
• The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer#1029930ClinicalTrials.gov
• A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications#1163140ClinicalTrials.gov
• Captive-Portal Identification Using DHCP or Router Advertisements (RAs)#132361IETF RFCs
• Captive-Portal Identification in DHCP and Router Advertisements (RAs)#243889IETF RFCs